Страна: Канада
Език: английски
Източник: Health Canada
AMOXICILLIN (AMOXICILLIN TRIHYDRATE); CLAVULANIC ACID (POTASSIUM CLAVULANATE)
ZOETIS CANADA INC
100MG; 25MG
TABLET (CHEWABLE)
AMOXICILLIN (AMOXICILLIN TRIHYDRATE) 100MG; CLAVULANIC ACID (POTASSIUM CLAVULANATE) 25MG
ORAL
15G/50G
Prescription
CATS; DOGS
Active ingredient group (AIG) number: 0234720002
APPROVED
2019-06-19
CLAVAMOX chewable tablets Zoetis version January 28, 2020 LEAFLET DIN 02489473 DIN 02489481 DIN 02489503 DIN 02489511 CLAVAMOX ® _amoxicillin and clavulanate potassium chewable tablets _ _ _ Veterinary Use Only DESCRIPTION: CLAVAMOX ® (amoxicillin and clavulanate potassium_ _chewable tablets) is an orally administered formulation comprised of the broad-spectrum antibiotic amoxicillin (as amoxicillin trihydrate) and the β-lactamase inhibitor clavulanic acid (as clavulanate potassium). MEDICINAL INGREDIENTS: - Each 62.5 mg chewable tablet strength contains 50 mg amoxicillin (as amoxicillin trihydrate) and 12.5 mg clavulanic acid (as clavulanate potassium). - Each 125 mg chewable tablet strength contains 100 mg amoxicillin (as amoxicillin trihydrate) and 25 mg clavulanic acid (as clavulanate potassium). - Each 250 mg chewable tablet strength contains 200 mg amoxicillin (as amoxicillin trihydrate) and 50 mg clavulanic acid (as clavulanate potassium). - Each 375 mg chewable tablet strength contains 300 mg amoxicillin (as amoxicillin trihydrate) and 75 mg clavulanic acid (as clavulanate potassium). INDICATIONS: CLAVAMOX chewable tablets are indicated for the treatment of: DOGS: _Skin and Soft Tissue Infections _such as wounds, abscesses, cellulitis, superficial/juvenile and deep pyoderma due to susceptible strains of the following bacteria: • β-lactamase-producing _Staphylococcus aureus _ • non- β-lactamase-producing _Staphylococcus aureus _ • _Staphylococcus _spp., _Streptococcus _spp., and _E. coli _ _Urinary Tract Infections _(cystitis) due to susceptible strains of _E. coli_. _Gingivitis associated with periodontal infections _due to susceptible strains of aerobic and anaerobic bacteria. CATS: _Skin and Soft Tissue Infections _such as wounds, abscesses, and cellulitis/dermatitis due to susceptible strains of the following bacteria: • β-lactamase-producing _Staphylococcus aureus _ • non- β-lactamase-producing _Staphylococcus aureus _ • _Staphylococcus _spp., _Streptococcus _spp., _E. coli_, and _P Прочетете целия документ